.
MergerLinks Header Logo

New Deal

New Deal

Cover Image David Burgstahler
David BurgstahlerAVISTA CAPITAL PARTNERS LP

David Burgstahler

CEO at AVISTA CAPITAL PARTNERS LP

Investor

Deal Bio

Total Deals17
Valued Deals5
Total Value£1,411M
Avg. Deal Size£282M
United States
Pharmaceuticals
AcquisitionPrivatePrivate Equity
G&w Dermatology

target

G&w Dermatology

Avista Capital Partners

bidder

Avista Capital Partners

value n/a

6 dealmakers

Sweden
Pharmaceuticals
PrivateAcquisitionPrivate EquityMajority
Trimb Holding

target

Trimb Holding

Karo Pharma

bidder

Karo Pharma

£275m

54 dealmakers

United States
Marine Transportation
AcquisitionPrivatePrivate EquityMajority
SEA-VISTA

target

SEA-VISTA

Seacor Holdings

bidder

Seacor Holdings

£88m

10 dealmakers

Belgium
Health Care Services
AcquisitionPrivateMajorityPrivate EquityCross Border
Vision Healthcare

target

Vision Healthcare

Avista Capital Partners

bidder

Avista Capital Partners

£273m

57 dealmakers

United States
Software
Private EquityDomesticDisposalMajorityPrivateAcquisition
Xifin

target

Xifin

Avista Capital Partners

bidder

Avista Capital Partners

value n/a

13 dealmakers

United States
Private Equity
DomesticAcquisitionPrivateMinorityPrivate Equity
Avista Capital Partners

target

Avista Capital Partners

Capital Constellation

bidder

Capital Constellation

value n/a

5 dealmakers

United States
Specialty Chemicals
DomesticPrivate EquityPrivateAcquisitionMinority
EMOLECULES

target

EMOLECULES

Avista Capital Partners

bidder

Avista Capital Partners

value n/a

16 dealmakers

United States
Biotechnology
Spin OffDomesticAcquisitionPrivateDe-SPACMajorityReverse TakeoverPrivate Equity
Omniab

target

Omniab

Avista Public Acquisition Corp Ii

bidder

Avista Public Acquisition Corp Ii

£643m

36 dealmakers

Canada
Medical Services
AcquisitionCross BorderPrivateMajorityPrivate Equity
Canute Medical

target

Canute Medical

Avista Capital Partners

bidder

Avista Capital Partners

value n/a

4 dealmakers

United States
Medical Services
Private EquityDomesticAcquisitionPrivateMajority
Inform Diagnostics

target

Inform Diagnostics

Fulgent Genetics

bidder

Fulgent Genetics

£130m

15 dealmakers

United States
Medical Supplies
PrivateAcquisitionMajorityPrivate EquityDomestic
DRYSHIELD

target

DRYSHIELD

Avista Capital Partners

bidder

Avista Capital Partners

value n/a

8 dealmakers

United Kingdom
Medical Equipment
PrivateMajorityAcquisitionCross BorderPrivate Equity
Mi Healthcare

target

Mi Healthcare

Avista Capital Partners

bidder

Avista Capital Partners

value n/a

6 dealmakers

United States
Medical Equipment
AcquisitionPrivateMajorityDomesticPrivate Equity
Ultra Select Medical

target

Ultra Select Medical

Probo Medical

bidder

Probo Medical

value n/a

6 dealmakers

United States
Medical Equipment
DomesticMajorityAcquisitionPrivate EquityPrivate
National Ultrasound

target

National Ultrasound

Probo Medical

bidder

Probo Medical

value n/a

6 dealmakers

Netherlands
Specialty Chemicals
AcquisitionMajorityCross BorderPrivate EquityPrivate
Specs Compound Handling

target

Specs Compound Handling

EMOLECULES

bidder

EMOLECULES

value n/a

6 dealmakers

United States
Medical Supplies
PrivateAcquisitionDomesticPrivate EquityMajority
Impladent

target

Impladent

Avista Capital Partners

bidder

Avista Capital Partners

value n/a

9 dealmakers

Germany
Personal Products
Cross BorderPrivatePrivate EquityAcquisitionMajority
Bayer (skin Care Brands)

target

Bayer (skin Care Brands)

Wellspring Consumer Healthcare

bidder

Wellspring Consumer Healthcare

value n/a

27 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US